[The association between Helicobacter pylori and gastric neoplasia. Epidemiologic evidence]

Rev Gastroenterol Mex. 2000 Oct-Dec;65(4 Suppl 2):20-4.
[Article in Spanish]

Abstract

Helicobacter pylori (HP) causes chronic gastritis and, together with non-steroidal anti-inflammatory drugs, is considered the most frequent etiologic agent of peptic ulcer. Since there are numerous epidemiologic and pathogenesis studies that demonstrate an association between infection by HP and gastric neoplasias, the World Health Organization declared, in 1994, HP infection a Group 1 carcinogen (a definitive cause of human neoplasias, similar to tobacco). This article reviews the epidemiological evidence supporting the association between HP infection and two gastric neoplasias: adenocarcinoma and B cell lymphoma associated to mucosas (MALT). This article also presents preliminary results of a project performed in the mountainous region of Chiapas, Mexico, in which the decrease of precancerous gastric lesions were studied one year after treatment for HP infection.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / epidemiology*
  • Adenocarcinoma / etiology
  • Adenocarcinoma / microbiology
  • Adenocarcinoma / prevention & control
  • Amoxicillin / therapeutic use
  • Clarithromycin / therapeutic use
  • Comorbidity
  • Double-Blind Method
  • Drug Therapy, Combination / therapeutic use
  • Enzyme Inhibitors / therapeutic use
  • Gastric Mucosa / microbiology
  • Gastric Mucosa / pathology
  • Gastritis, Atrophic / microbiology
  • Gastritis, Atrophic / pathology
  • Helicobacter Infections / complications
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / epidemiology*
  • Helicobacter pylori / isolation & purification
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / epidemiology*
  • Lymphoma, B-Cell, Marginal Zone / etiology
  • Lymphoma, B-Cell, Marginal Zone / microbiology
  • Lymphoma, B-Cell, Marginal Zone / prevention & control
  • Metaplasia
  • Mexico / epidemiology
  • Omeprazole / therapeutic use
  • Precancerous Conditions / epidemiology
  • Precancerous Conditions / etiology
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Retrospective Studies
  • Stomach Neoplasms / epidemiology*
  • Stomach Neoplasms / etiology
  • Stomach Neoplasms / microbiology
  • Stomach Neoplasms / prevention & control
  • Stomach Ulcer / epidemiology
  • Stomach Ulcer / etiology
  • Stomach Ulcer / microbiology
  • Stomach Ulcer / prevention & control

Substances

  • Enzyme Inhibitors
  • Amoxicillin
  • Clarithromycin
  • Omeprazole